{"entity":{"id":"paper-pugh-self-experimentation-publication-jme-2026","kind":"paper","name":"Pugh 2026: should a journal publish a scientist's experiment on herself?","aka":[],"tldr":"Three ethicists work through whether it was right to publish the virologist's case, separating the question of whether she should have done it from whether the result should have been printed.","summary":"Pugh, Wilkinson and Savulescu take the 2024 self-experimentation case report as their worked example and separate two questions that are usually run together: the performance question, whether it is ethical to experiment on oneself, and the publication question, whether it is ethical to publish the findings as research. They note that the case report's authors reported difficulty publishing because of concerns raised about the ethics of self-experimentation.\n\nThey argue that self-experimentation is not inherently unethical, and equally that there is no reason in principle to exempt it from ethical evaluation. Applying respect for autonomy, reasonable risk and prevention of harm to others, they conclude that publication of this particular report can be morally justified: the self-experimenter understood the choice, the viruses had a good safety profile, and the authors were explicit about the limited generalisability and that self-medication should not be a first approach. They note that live viruses do carry shedding and transmission risk to others, and that publication carries the separate risk of tempting other patients towards unconventional therapies before standard ones.\n\nThey recommend case-by-case assessment by ethics committees and journal editors rather than a blanket rule, encourage self-experimenters to seek review where publication is foreseeable, and give a decision algorithm. They set the case in a long history that includes Werner Forssmann and Barry Marshall, who both later received Nobel prizes, and scientists who died of their own experiments.","asOf":"2026-09-25","links":[{"label":"J Med Ethics 2026 (open access)","url":"https://doi.org/10.1136/jme-2025-110730"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/40930709/"},{"label":"Europe PMC full text","url":"https://europepmc.org/articles/PMC7618749"}],"tags":[],"related":["paper-halassy-self-experiment-ovt-vaccines-2024"],"cancers":[],"sections":["immunotherapy"],"technologies":["oncolytic-virus"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["beata-halassy"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"Journal of Medical Ethics","year":2026,"doi":"10.1136/jme-2025-110730","pmid":"40930709","authors":"Pugh J, Wilkinson D, Savulescu J","paperType":"review","findings":["The performance question and the publication question are distinct: liberal norms of non-interference may govern whether a person may experiment on themselves, but not whether the result should be published as research.","Self-experimentation is not inherently unethical, and is not in principle exempt from ethical evaluation either.","Live oncolytic viruses expose others to shedding and unintentional transmission risk, which is a genuine harm-to-others consideration, mitigable by storage, handling and administration protocols.","Publication can tempt other patients towards unconventional therapy ahead of standard treatment, which is a reason for authors to state limits explicitly, as these authors did.","The authors conclude that publishing this report was morally justifiable, and propose a decision algorithm for editors facing similar submissions."],"whatItMeans":"The reason this case matters beyond one tumour is that it forced journals to decide a question they had avoided. The answer these authors give is not permission: it is that each case needs assessing against the values ethics committees exist to protect, and that a self-experimenter who expects to publish should seek review beforehand. For a reader the practical point is the one both papers make, that a published case is a record of what happened to one person and not an instruction.","caveats":["A normative ethics paper, not empirical research; the decision algorithm is a proposal and has no formal standing.","It analyses a case in which the self-experimenter was a professional virologist with laboratory access, and the authors are explicit that the reasoning does not extend to amateur self-experimentation.","One declared interest: a bioethics consultancy and advisory roles are disclosed by one author."]},"route":"/key-papers/paper-pugh-self-experimentation-publication-jme-2026/","neighbours":{"paper":[{"id":"paper-halassy-self-experiment-ovt-vaccines-2024","kind":"paper","name":"The self-experiment: a virologist treated her own recurrent breast cancer with two viruses she made in her own laboratory","route":"/key-papers/paper-halassy-self-experiment-ovt-vaccines-2024/"}],"section":[{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"}],"technology":[{"id":"oncolytic-virus","kind":"technology","name":"Oncolytic viruses","route":"/technologies/oncolytic-virus/"}],"person":[{"id":"beata-halassy","kind":"person","name":"Beata Halassy","route":"/people/beata-halassy/"}]}}